Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
California Pacific Medical Center
InstitutionResearch output, impact & collaborations
California Pacific Medical Center is a research organisation in San Francisco, US. OpenAlex records 8,691 works and 972,639 citations for it. 1,479 researchers list it as their most recent affiliation.
8,691
Works
972,639
Citations
1,479
Researchers
42.5
Avg h-index
How has California Pacific Medical Center's publication output changed over time?
ScholarIQpublication output · 1985–2021
Output grew0% over the shown period — from 1 works in 1985 to 1 in 2021.
1
1
1
1
4
2
1
1
19851993199920082012201320152021
Who are the most-cited researchers behind California Pacific Medical Center?
ScholarIQtop researchers by citations
What are the most-cited papers on California Pacific Medical Center?
ScholarIQmost cited works
Surviving Sepsis Campaign
R. Phillip Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan Sevransky, Charles L. Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth Kleinpell, Derek C. Angus, Clifford S. Deutschman, Flávia Ribeiro Machado, Gordon D. Rubenfeld, S. A. R. Webb, Richard Beale, Jean‐Louis Vincent, Rui P. Moreno
Critical Care Medicine. 20139,750 Citations
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
R.P. Dellinger, Mitchell M. Levy, Andrew Rhodes, Djillali Annane, Herwig Gerlach, Steven M. Opal, Jonathan Sevransky, Charles L. Sprung, Ivor S. Douglas, Roman Jaeschke, Tiffany M. Osborn, Mark Nunnally, Sean R. Townsend, Konrad Reinhart, Ruth Kleinpell, Derek C. Angus, Clifford S. Deutschman, Flávia Ribeiro Machado, Gordon D. Rubenfeld, S. A. R. Webb, Richard Beale, Jean‐Louis Vincent, Rui P. Moreno
Intensive Care Medicine. 20137,357 CitationsOPEN ACCESS
Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial
Andrew X. Zhu, Joon Oh Park, Baek‐Yeol Ryoo, Chia-Jui Yen, Ronnie T. P. Poon, Davide Pastorelli, Jean-Frédéric Blanc, Hyun Cheol Chung, Ari David Baron, Túlio Pfiffer, Takuji Okusaka, Kateřina Kubáčková, Jörg Trojan, Javier Sastre, Ian Chau, Shao-Chun Chang, Paolo Abada, Ling Yang, Jonathan D. Schwartz, Masatoshi Kudo
The Lancet Oncology. 2015846 CitationsOPEN ACCESS
Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial
Gerald S. Falchook, Karl D. Lewis, Jeffrey R. Infante, Michael S. Gordon, Nicholas J. Vogelzang, Douglas J. DeMarini, Peng Sun, Christopher Moy, Stephen A. Szabo, Lori Roadcap, Vijay Peddareddigari, Peter F. Lebowitz, Ngocdiep T. Le, Howard A. Burris, Wells A. Messersmith, Peter J. O’Dwyer, Kevin B. Kim, Keith T. Flaherty, Johanna C. Bendell, René González, Razelle Kurzrock, Leslie A. Fecher
The Lancet Oncology. 2012545 CitationsOPEN ACCESS
Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Van der Merwe, Roy L.J. van Wanrooij, Michiel Bronswijk, Simon Everett, Sundeep Lakhtakia, Mihai Rimbaș, Tomáš Hucl, Rastislav Kunda, Abdenor Badaoui, Ryan Law, Paolo Giorgio Arcidiacono, Alberto Larghi, Marc Giovannini, Mouen A. Khashab, Kenneth F. Binmoeller, Marc Barthet, Manuel Pérez‐Miranda, Jeanin E. van Hooft
Endoscopy. 2021488 CitationsOPEN ACCESS
How much of the research on California Pacific Medical Center is open access?
ScholarIQopen access share
42%OPEN ACCESS
Gold
0%
Green
25%
Hybrid
0%
Bronze
17%
Closed
58%